Patent US4725550A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4725550A Expired / Lapsed US ⏱️ 0.0 years remaining

Novel mutation of the c-K-ras oncogene activated in a human lung carcinoma

Assignee: Research Foundation of the State University of New York
•
Filing: 1984-01-19
•
Granted: 1988-02-16
•
Expires: 2004-01-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A c-Kirsten _r oncogene has been isolated from a human lung tumor cell line. This c-Kirsten _r has a mutation in codon 61 of the second coding exon and is capable of transforming NIH/3T3 mouse fibroblast cells to tumorigenic cells.

Inventors

  • 👤 Manuel Perucho
  • 👤 Hirofumi Nakano
  • 👤 Fumiichiro Yamamoto
  • 👤 Craig Neville

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-01 12:38
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/82; A; A61; A61P; A61P43/00

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 31 words
Purified DNA from a human c-K ras gene capable of transforming NIH3T3 mouse fibroblast cells to tumorigneic cells, said DNA containing a mutation in codon 61 of the second exon thereof.
Claim 2
Dependent Claim 31 words
Purified DNA from a human c-K ras gene capable of transforming NIH3T3 mouse fibroblast cells to tumorigneic cells, said DNA containing a mutation in codon 61 of the second exon thereof.
Claim 3
Dependent Claim 23 words
Purified DNA of claim 1 wherein the c-K ras gene is derived from the human lung carcinoma line PR 310 (ATCC CRL- 8477).
Claim 4
Dependent Claim 15 words
Purified DNA of claim 1 wherein the mutation is a transversion in said codon 61.
Claim 5
Dependent Claim 17 words
Purified DNA of claim 3 wherein the transversion is in the third base of said codon 61.
Claim 6
Dependent Claim 12 words
Purified DNA of claim 4 wherein the transversion is an A→T transversion.
Claim 7
Dependent Claim 158 words
Purified DNA comprising the nucleotide sequence: __________________________________________________________________________ ATG ACT GAA TAT AAA CTT GTG GTA GTT GGA GCT GGT GGC GTA GGC AAG AGT GCC TTG ACG ATA CAG CTA ATT CAG AAT CAT TTT GTG GAC GAA TAT GAT CCA ACA ATA GAG GAT TCC TAC AGG AAG CAA GTA GTA ATT GAT GGA GAA ACC TGT CTC TTG GAT ATT CTC GAG ACA GCA GGT CAT GAG GAG TAC AGT GCA ATG AGG GAC CAG TAC ATG AGG ACT GGG GAG GGC TTT CTT TGT GTA TTT GCC ATA AAT AAT ACT AAA TCA TTT GAA GAT ATT CAC CAT TAT AGA GAA CAA ATT AAA AGA GTT AAG GAC TCT GAA GAT GTA CCT ATG GTC CTA GTA GGA AAT AAA TGT GAT TTG CCT TCT AGA ACA GTA GAC ACA AAA CAG GCT CAG GAC TTA GCA AGA AGT TAT GGA ATT CCT TTT ATT GAA ACA TCA GCA AAG ACA AGA __________________________________________________________________________ CAG
Claim 8
Dependent Claim 158 words
Purified DNA comprising the nucleotide sequence: __________________________________________________________________________ ATG ACT GAA TAT AAA CTT GTG GTA GTT GGA GCT GGT GGC GTA GGC AAG AGT GCC TTG ACG ATA CAG CTA ATT CAG AAT CAT TTT GTG GAC GAA TAT GAT CCA ACA ATA GAG GAT TCC TAC AGG AAG CAA GTA GTA ATT GAT GGA GAA ACC TGT CTC TTG GAT ATT CTC GAG ACA GCA GGT CAT GAG GAG TAC AGT GCA ATG AGG GAC CAG TAC ATG AGG ACT GGG GAG GGC TTT CTT TGT GTA TTT GCC ATA AAT AAT ACT AAA TCA TTT GAA GAT ATT CAC CAT TAT AGA GAA CAA ATT AAA AGA GTT AAG GAC TCT GAA GAT GTA CCT ATG GTC CTA GTA GGA AAT AAA TGT GAT TTG CCT TCT AGA ACA GTA GAC ACA AAA CAG GCT CAG GAC TTA GCA AGA AGT TAT GGA ATT CCT TTT ATT GAA ACA TCA GCA AAG ACA AGA __________________________________________________________________________ CAG
Claim 9
Dependent Claim 15 words
Purified DNA of claim 1 having the partial nucleotide sequence of the second coding exon.
Claim 10
Dependent Claim 15 words
Purified DNA of claim 2 having the partial nucleotide sequence of the second coding exon.
Claim 11
Dependent Claim 15 words
Purified DNA of claim 6 having the partial nucleotide sequence of the second coding exon.
Claim 12
Dependent Claim 9 words
A cloning vector containing the DNA of claim 1.
Claim 13
Dependent Claim 13 words
The cloning vector of claim 10 which is a bacterial plasmid or bacteriophage.
Claim 14
Dependent Claim 11 words
The cloning vector of claim 11 which is a pBR322 plasmid.
Claim 15
Dependent Claim 9 words
A cloning vector containing the DNA of claim 2.
Claim 16
Dependent Claim 13 words
The cloning vector of claim 13 which is a bacterial plasmid or bacteriophage.
Claim 17
Dependent Claim 11 words
The cloning vector of claim 14 which is a pBR322 plasmid.
Claim 18
Dependent Claim 9 words
A cloning vector containing the DNA of claim 6.
Claim 19
Dependent Claim 13 words
The cloning vector of claim 16 which is a bacterial plasmid or bacteriophage.
Claim 20
Dependent Claim 11 words
The cloning vector of claim 17 which is a pBR322 plasmid.

References Cited (Backward Citations)

US4535058A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1991-02-15 1991-08-17 1992-02-16 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1995-02-15 1995-08-17 1996-02-16 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1999-02-15 1999-08-17 2000-02-16 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag